Committees’ Report On Emergent BioSolutions Uncovers Extensive Vaccine Manufacturing Failures, Deliberate Efforts To Hide Deficiencies

May 10, 2022
Reports

Staff Report: "The Coronavirus Manufacturing Failures of Emergent BioSolutions" [PDF]

Connect with the Subcommittee

Twitter | Facebook | Instagram | YouTube

2157 Rayburn House Office Building, Washington, D.C. 20515
(202) 225-4400